article thumbnail

Research shows sotagliflozin is the first medication of its kind to significantly reduce both heart attacks and strokes

Medical Xpress - Cardiology

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart attack and stroke among these patients, according to results from an international clinical trial led by a Mount Sinai researcher.

article thumbnail

You Are Being Lied To About Cholesterol & Heart Disease.

Dr. Paddy Barrett

“Cholesterol does not cause heart disease.“ “ “Statins do not prevent heart attacks.” In the middle of this hurricane of noise are people who just want to know what to do so they don’t have a heart attack at a young age. But other factors also play a role.

article thumbnail

Why Waiting Until Age 50 To Address Risk Factors For Heart Disease Is Too Late.

Dr. Paddy Barrett

When you look at the risk of having a heart attack, it is true that the older you are, the greater the odds of having a heart attack 1. While only 1-2% of those having a heart attack are less than 65 years of age, 1-2% of this very large number means a LOT of heart attacks.

article thumbnail

Five Tests To Assess Your Heart Health In The New Year.

Dr. Paddy Barrett

Blood Pressure High blood pressure is the risk factor responsible for the greatest number of deaths worldwide 2. For every 20mmHg increase in systolic (Top Number) blood pressure, the risk of dying from a heart attack or stroke doubles 3. Maybe it’s time to get more movement into your day.

article thumbnail

SGLT-2 Inhibitors Show Mixed Results After Heart Attack

DAIC

However, researchers said the drug may be helpful in reducing heart failure risks, including hospitalization, following a heart attack. The study enrolled 6,522 people treated for acute myocardial infarction at 451 centers in 22 countries. About 32% had Type 2 diabetes.

article thumbnail

No Reduction in 90-Day Deaths, Heart Attacks With Human Apo/A1, A Building Block of HDL Cholesterol

DAIC

milla1cf Sat, 04/06/2024 - 18:32 April 6, 2024 — The first trial of a novel strategy for removing cholesterol from patients’ arteries did not reduce the risk of death, heart attack or stroke within three months of a prior heart attack, according to research presented at the American College of Cardiology ’s Annual Scientific Session.

article thumbnail

Can gardening ward off heart attacks?

Heart Sisters

This study looked at what gardeners already suspect: "Gardening is associated with better cardiovascular health among older adults compared to older adults who do not garden"